The fourth edition of Sweet Biopharma Day, which concluded successfully on October 9 at Espace Tonik in Sainte-Julie, once again showcased the vitality and collaborative spirit of Quebec's biopharmaceutical industry. Organized by adMare BioInnovations, AmorChem, BIOQuébec, CQDM, and the Fonds de solidarité FTQ, this invitation-only event allowed 16 innovative companies to present their projects to a prestigious audience, composed of influential industry representatives.
Read MoreOn October 4th, Biodextris, a member of BIOQuébec, inaugurated its brand-new facilities, made possible through an investment of nearly $25 million. These state-of-the-art infrastructures are designed to support the development of complex bioprocesses and biological products, further solidifying the company's role in life sciences innovation in Quebec.
Read MoreAccelerate your career with the Life Sciences Entrepreneurship Development Program (PDESV). This 10-month hands-on program focuses on pharmaceutical product and medical device development. Led by industry experts, it equips participants with the essential skills to succeed in the life sciences sector.
Read MoreJoin this exceptional event that brings together internationally renowned experts, visionary start-ups, and leading researchers from Canada and Italy. This event is a unique opportunity to discover innovative projects and forge valuable connections with key players in the industry.
Read MoreThe PEACe 2025 conference (Protein Expression in Animal Cells), taking place in Montreal from September 14 to 18, 2025, offers an invaluable opportunity for life sciences companies to connect with world-renowned experts, influential researchers, and key decision-makers specializing in recombinant protein expression
Read MoreLaval, Québec – September 10, 2024 – BIOQuébec, BioNJ, and Choose New Jersey are pleased to announce a new Memorandum of Understanding (MOU) that aims to enhance cooperation and collaboration between the life sciences sectors in Québec and New Jersey, signed during Choose New Jersey’s Governor-led economic mission in Canada.
Read MoreOf the 7,000 known rare diseases, less than 10 per cent have an effective drug therapy. Of these, about 60 per cent are brought to Canada, where it can take up to an additional six years for approval versus the US or Europe.
Read MoreMONTREAL, July 4, 2024 — Mila - Quebec Artificial Intelligence Institute is pleased to announce a partnership with Sorintellis, a Montreal-based AI company whose mission is to innovate pharmaceutical portfolio management using a data-driven approach and artificial intelligence (AI) technologies.
Read MoreLaval, Québec / Frederick, Maryland – June 3, 2024 – BIOQuébec and the Maryland Tech Council (MTC) are delighted to announce a new Memorandum of Understanding (MOU) that will enhance cooperation and collaboration between life sciences sectors in Québec and Maryland. This partnership aims to foster mutual benefits and strengthen biopharma and biotech industries in both regions through shared information and opportunities.
Read MoreMONTREAL--(BUSINESS WIRE)--Neurenati Therapeutics is delighted to announce the Quebec Government’s investment of $1.38 million via its Impulsion PME program, for which Investissement Québec acts as agent. With the addition of angel investors, this brings the total funding to $2.9 million needed for Neurenati to effectively advance NEU-001 toward clinical trials. NEU-001 is a proposed first-in-class therapy to treat Hirschsprung's disease, a rare gastrointestinal disease affecting approximately 1,300 newborns in North America each year.
Read MoreMontreal, QC – The Canadian Alliance for Skills and Training in Life Sciences (CASTL) announced today they have signed a memorandum of understanding (MOU) with Moderna Canada to support biomanufacturing training for employees at Moderna’s new vaccine manufacturing facility in Laval, Quebec.
Read MoreMONTREAL, February 1, 2024 – ExCellThera Inc. (ExCellThera), a world leader in enhanced blood stem cell therapies, announced today a publication in the journal Blood that further elucidates the UM171 mechanism of action and highlights the potential for UM171 to result in the efficient expansion of stem cells with preserved function for therapeutic use.
Read MoreBIOQuébec has spoken out several times in recent years in favour of effective changes to the regulatory framework governing drug pricing in Canada. This is an extremely important issue for the development of the life sciences sector, in a context where medical advances are accelerating and taking on a global scope. Canadians cannot afford to see their economy left behind in this technological revolution as a result of misguided public policies that undermine the significant investments made by both the private and public sectors.
Read MoreMONTREAL, Dec. 12, 2023 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and metabolic fitness, announced today positive results from 50 patients in two multi-center Phase 2 trials for UM171 cell therapy conducted at transplant centers in the U.S., Canada and Europe, building on prior strong data from a Phase 1/2 trial and comparative registry studies (CIBMTR and EBMT).
Read More(Charlottetown, PE –November 27, 2023) – Today, the Canadian Alliance for Skills and Training in Life Sciences (CASTL) announces the launch of its national biomanufacturing skills and training program – CASTL Elevate. CASTL Elevate is powered by Upskill Canada, and is part of the first wave of partnership programs that are taking an industry-informed approach to supporting workers in Canada’s fast-growing biomanufacturing sector.
Read MoreQuébec, Canada, November 28, 2023- Linearis Labs Inc (“Linearis”), an innovative company at the intersection of AI and biomarker analysis, announces today the inauguration of its new laboratory facilities at a site formerly occupied by Medicago Inc (“Medicago”). Following the announcement of the cessation of their operations after 26 years, Linearis acquired over 650 scientific instruments and hired some of their most seasoned specialized personnel in mass spectrometry, quality assurance, and laboratory management.
Read MoreVancouver (BC), Toronto (ON), and Montreal (QC) (November 21, 2023) - The adMare Institute released today the findings of its first white paper, considering the critical factors required to build a thriving life sciences industry and the essential role played by anchor companies.
Read MoreLaval, Québec & West Palm Beach, Florida, October 13, 2023 — BIOQuébec and BioFlorida, preeminent life sciences associations from Québec and Florida, are proud to announce the signing of a Memorandum of Understanding (MOU). This agreement is set to intensify collaboration and bolster industry growth in of both regions.
Read MoreThe Ministère de l’Économie, de l’Innovation et de l’Énergie is issuing a call for projects to meet the innovation and commercialization needs of businesses and organizations, to help them become more competitive, ensure their growth and productivity, and integrate a culture of innovation into their practices, by creating a position of innovation and commercialization manager.
Read MoreMcGill University today announced it has signed agreements with ModernaTX, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, to support two innovative research projects in the area of lipid nanoparticles (LNPs). LNPs are critical components in mRNA medicines such as vaccines, as they are the primary delivery method of mRNA strands to the target cells.
Read More
